IB 

Union Calendar No. 556 

115TH CONGRESS 

2D SESSION H. R. 5582 

[Report No. 115–721, Part I] 

To direct the Secretary of Health and Human Services to conduct a study 

and submit a report on barriers to accessing abuse-deterrent opioid 

formulations for individuals enrolled in a plan under part C or D of 

the Medicare program. 

IN THE HOUSE OF REPRESENTATIVES 

APRIL 23, 2018 

Mr. CARTER of Georgia (for himself, Mr. LOEBSACK, and Mr. REED) introduced the following bill; which was referred to the Committee on Energy 

and Commerce, and in addition to the Committee on Ways and Means, 

for a period to be subsequently determined by the Speaker, in each case 

for consideration of such provisions as fall within the jurisdiction of the 

committee concerned 

JUNE 8, 2018 

Additional sponsors: Mr. MICHAEL F. DOYLE of Pennsylvania, Mrs. 

BLACKBURN, Mr. WALDEN, and Mr. MCHENRY

JUNE 8, 2018 

Reported from the Committee on Energy and Commerce with an amendment 

[Strike out all after the enacting clause and insert the part printed in italic] 

JUNE 8, 2018 

The Committee on Ways and Means discharged; committed to the Committee 

of the Whole House on the State of the Union and ordered to be printed 

[For text of introduced bill, see copy of bill as introduced on April 23, 2018] 


lotter on DSKBCFDHB2PROD with BILLS
2 

•HR 5582 RH

A BILL 

To direct the Secretary of Health and Human Services to 

conduct a study and submit a report on barriers to 

accessing abuse-deterrent opioid formulations for individuals enrolled in a plan under part C or D of the Medicare program. 


lotter on DSKBCFDHB2PROD with BILLS
3 

•HR 5582 RH

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited at the ‘‘Abuse Deterrent Access 

5 Act of 2018’’. 

6 SEC. 2. STUDY ON ABUSE-DETERRENT OPIOID FORMULA7 TIONS ACCESS BARRIERS UNDER MEDICARE. 

8 (a) IN GENERAL.—Not later than one year after the 

9 date of the enactment of this Act, the Secretary of Health 

10 and Human Services shall conduct a study and submit to 

11 Congress a report on the adequacy of access to abuse-deter12 rent opioid formulations for individuals with chronic pain 

13 enrolled in an MA–PD plan under part C of title XVIII 

14 of the Social Security Act or a prescription drug plan 

15 under part D of such title of such Act, taking into account 

16 any barriers preventing such individuals from accessing 

17 such formulations under such MA–PD or part D plans, 

18 such as cost-sharing tiers, fail-first requirements, the price 

19 of such formulations, and prior authorization requirements. 

20 (b) DEFINITION OF ABUSE-DETERRENT OPIOID FOR21 MULATION.—In this section, the term ‘‘abuse-deterrent 

22 opioid formulation’’ means an opioid that is a prodrug or 

23 that has certain abuse-deterrent properties, such as physical 

24 or chemical barriers, agonist or antagonist combinations, 


lotter on DSKBCFDHB2PROD with BILLS
4 

•HR 5582 RH

1 aversion properties, delivery system mechanisms, or other 

2 features designed to prevent abuse of such opioid. 


lotter on DSKBCFDHB2PROD with BILLS

lotter on DSKBCFDHB2PROD with BILLS
Union Calendar No. 556 

115TH CONGRESS 

2D SESSION H. R. 5582 

[Report No. 115–721, Part I] 

A BILL 

To direct the Secretary of Health and Human 

under part C or D of the Medicare program. formulations for individuals enrolled in a plan on barriers to accessing abuse-deterrent opioid Services to conduct a study and submit a report 

JUNE 8, 2018 

Reported from the Committee on Energy and Commerce 

with an amendment 

JUNE 8, 2018 

The Committee on Ways and Means discharged; comState of the Union and ordered to be printed mitted to the Committee of the Whole House on the 


lotter on DSKBCFDHB2PROD with BILLS